{"id":"https://genegraph.clinicalgenome.org/r/973cbbfb-50e0-4888-bb59-b4cb6c348929v1.0","type":"EvidenceStrengthAssertion","dc:description":"The relationship between *COA7* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of August 22, 2024. The *COA7* gene encodes an assembly factor for complex IV of the mitochondrial respiratory chain. The COA7 protein also acts as a heme binding protein with disulfide reductase activity. \n\n*COA7* was first reported in relation to autosomal recessive primary mitochondrial disease in 2016 (PMID: 27683825). While various names could be given to the constellation of features seen in those with *COA7*-related disorders, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the COA7 phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. \n\nEvidence supporting this gene-disease relationship includes case-level data and experimental data. This curation included 12 variants [nine missense variants including a founder variant, NM_023077.3:c.17A>G (p.Asp6Gly), one nonsense variant, one frameshift variant, and one splicing variant) in eight probands from six publications (PMIDs: 29718187, 35603692, 37264311, 37750949, 34322155, 27683825). Clinical features in affected individuals include leukodystrophy, spinocerebellar ataxia, Parkinsonism, neuropathy, tremor, weakness, ataxia, dysarthria, and cardiomyopathy. Onset ranges from childhood to adulthood. Mild elevations of lactate and creatine kinase have been reported.\n\nThe mechanism of disease is loss of function This gene-disease association is also supported by its known biochemical function of the COA7 protein in the assembly of complex IV, functional alteration in patient cells and non-patient cells, rescue studies performed in HEK293T cells, and a *Drosophila* model (PMIDs: 29718187, 24333015, 29718187, 35210360).\n\nIn summary, there is definitive evidence to support the relationship between *COA7* and primary mitochondrial disease. This relationship has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on August 22, 2024 (SOP Version 10).","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/973cbbfb-50e0-4888-bb59-b4cb6c348929","GCISnapshot":"https://genegraph.clinicalgenome.org/r/971c1202-83cf-4ad1-9404-c4ef2fcf0880","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/971c1202-83cf-4ad1-9404-c4ef2fcf0880_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2025-01-09T23:18:48.509Z","role":"Publisher"},{"id":"https://genegraph.clinicalgenome.org/r/971c1202-83cf-4ad1-9404-c4ef2fcf0880_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10027","date":"2024-08-22T04:00:00.000Z","role":"Approver"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/971c1202-83cf-4ad1-9404-c4ef2fcf0880_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0c3d0ebe-e83b-4fb0-b3af-07be09707d99_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cba3761e-b50b-428d-b98e-5b5bbf734dc7","type":"EvidenceLine","dc:description":"0.1 (Rare missense variant + WES)\n+ 0.2 (borderline complex I deficiency in skin at 37%, reduction of complex IV by BN PAGE 60% of control)\n+0.4 PMID: 35210360 (Formosa et al 2022) shows that MT-CO1 and MT-CO2 are not rescued by D6G variant in COA7 KO Cells, but are by WT COA7)\n\n","calculatedScore":1.0,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cba3761e-b50b-428d-b98e-5b5bbf734dc7_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.1 (Rare missense variant + WES)\n+ 0.2 (borderline complex I deficiency in skin at 37%, reduction of complex IV by BN PAGE 60% of control)\n+0.4 PMID: 35210360 (Formosa et al 2022) shows that MT-CO1 and MT-CO2 are not rescued by D6G variant in COA7 KO Cells, but are by WT COA7)\n\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/cba3761e-b50b-428d-b98e-5b5bbf734dc7_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29718187","allele":{"id":"https://genegraph.clinicalgenome.org/r/8ffd2fc1-6380-42fa-9417-74e1937728fd","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_023077.3(COA7):c.17A>G (p.Asp6Gly)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA855787"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:Homozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/0c3d0ebe-e83b-4fb0-b3af-07be09707d99","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29718187","rdfs:label":"Higuchi et al 2018, Patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":63,"allele":{"id":"https://genegraph.clinicalgenome.org/r/8ffd2fc1-6380-42fa-9417-74e1937728fd"},"detectionMethod":"Mother is heterozygote\n2 unaffected siblings are het\n1 unaffected sibling WT homozygous\n\n14 alleles in gnomAD v4.1.0 (no homozygotes, AF: 0.000008687)\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0009830","obo:HP_0001765","obo:HP_0001251","obo:HP_0001761","obo:HP_0001272","obo:HP_0001260"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/cba3761e-b50b-428d-b98e-5b5bbf734dc7_variant_evidence_item"}}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/a3f3ad9c-9421-4679-9330-0e9f808170ab_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f2b195f-19d8-4a79-b8f0-1331afc3b660","type":"EvidenceLine","dc:description":"Recurrent founder variant with rescue data - score 0.5","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9f2b195f-19d8-4a79-b8f0-1331afc3b660_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Recurrent founder variant with rescue data","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9f2b195f-19d8-4a79-b8f0-1331afc3b660_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35603692","allele":{"id":"https://genegraph.clinicalgenome.org/r/8ffd2fc1-6380-42fa-9417-74e1937728fd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b875fe1c-e890-4352-801f-10b5d5cd5bcb","type":"EvidenceLine","dc:description":"1.5 (not predicted to undergo NMD \n+0.2 Multiple COX- fibers in 31 year old\n(normal fibroblasts)\n","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b875fe1c-e890-4352-801f-10b5d5cd5bcb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"1.5 (not predicted to undergo NMD - 0.5\n+0.2 Multiple COX- fibers in 31 year old\n(normal fibroblasts)\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/b875fe1c-e890-4352-801f-10b5d5cd5bcb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35603692","allele":{"id":"https://genegraph.clinicalgenome.org/r/bf2c0e37-06f3-4e13-9429-a248b296555f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_023077.3(COA7):c.554G>A (p.Trp185Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340362129"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.75},{"id":"https://genegraph.clinicalgenome.org/r/a3f3ad9c-9421-4679-9330-0e9f808170ab","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35603692","rdfs:label":"Tang et al 2022 proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":31,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/bf2c0e37-06f3-4e13-9429-a248b296555f"},{"id":"https://genegraph.clinicalgenome.org/r/8ffd2fc1-6380-42fa-9417-74e1937728fd"}],"detectionMethod":"c.17A>G; p. D6G  (paternal)\n14 alleles in gnomAD v4.1.0 (no homozygotes, AF: 0.000008687)\n\nc.554G>A, p.W185* (maternal)\nnot predicted to undergo NMD, but truncates ~20% of protein (185X/ 231)\n\nAbsent in gnomAD v4.1.0\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001251","obo:HP_0006827","obo:HP_0009830","obo:HP_0001272"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/b875fe1c-e890-4352-801f-10b5d5cd5bcb_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/9f2b195f-19d8-4a79-b8f0-1331afc3b660_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":2.25},{"id":"https://genegraph.clinicalgenome.org/r/045e62f6-f62e-414b-9912-b63ddf7fe87f_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86e60f4c-eb70-45bd-b66c-35e48abf1f1a","type":"EvidenceLine","dc:description":"Recurrent founder variant with rescue data score 0.5","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/86e60f4c-eb70-45bd-b66c-35e48abf1f1a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Recurrent founder variant with rescue data score 0.5","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/86e60f4c-eb70-45bd-b66c-35e48abf1f1a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29718187","allele":{"id":"https://genegraph.clinicalgenome.org/r/8ffd2fc1-6380-42fa-9417-74e1937728fd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/4c6033d7-ec50-46d6-bb51-e6c1a2a1b3a4","type":"EvidenceLine","dc:description":"1.5 – 0.5 (not predicted to undergo NMD), no functional studies","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4c6033d7-ec50-46d6-bb51-e6c1a2a1b3a4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"1.5 – 0.5 (not predicted to undergo NMD), no functional studies\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/4c6033d7-ec50-46d6-bb51-e6c1a2a1b3a4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29718187","allele":{"id":"https://genegraph.clinicalgenome.org/r/77890b17-5759-445e-91a8-6bcc0c218ccc","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_023077.3(COA7):c.431del (p.Gly144ValfsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA913189316"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/045e62f6-f62e-414b-9912-b63ddf7fe87f","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29718187","rdfs:label":"Higuchi et al 2018, Patient 4","ageType":"AgeAtReport","ageUnit":"Years","ageValue":27,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/77890b17-5759-445e-91a8-6bcc0c218ccc"},{"id":"https://genegraph.clinicalgenome.org/r/8ffd2fc1-6380-42fa-9417-74e1937728fd"}],"detectionMethod":"c.17A>G; p. D6G \n(Father carries)\n14 alleles in gnomAD v4.1.0 (no homozygotes, AF: 0.000008687)\n\nc.430delG;p. G144fs\n(mother carries); not predicted to undergo NMD\nAbsent in gnomAD v4.1.0\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001272","obo:HP_0009830","obo:HP_0003202","obo:HP_0001251"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/4c6033d7-ec50-46d6-bb51-e6c1a2a1b3a4_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/86e60f4c-eb70-45bd-b66c-35e48abf1f1a_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/3acabed4-9f68-4fd6-95e9-ef05d58bea6c_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ddeadc70-8168-4d4b-90f6-a26534f8366d","type":"EvidenceLine","dc:description":"0.1 (rare missense variant + WES)\n+0.2 (Complex IV activity by OxPhos 42% of control, parents were normal + maximal respiratory rate OCR in glucose and galcatose was 45-46% of control by OCR)\n","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ddeadc70-8168-4d4b-90f6-a26534f8366d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.1 (rare missense variant + WES)\n+0.2 (Complex IV activity by OxPhos 42% of control, parents were normal + maximal respiratory rate OCR in glucose and galcatose was 45-46% of control by OCR)\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/ddeadc70-8168-4d4b-90f6-a26534f8366d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34322155","allele":{"id":"https://genegraph.clinicalgenome.org/r/4ce03fda-9521-470c-8669-6aab9cdb5904","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_023077.3(COA7):c.511G>A (p.Ala171Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340362514"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/bb8ccf36-5632-4018-88a7-c2aa22c81bef","type":"EvidenceLine","dc:description":"0.1 (rare missense variant + WES)\n+0.2 (Complex IV activity by OxPhos 42% of control, parents were normal + maximal respiratory rate OCR in glucose and galcatose was 45-46% of control by OCR)\n","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/bb8ccf36-5632-4018-88a7-c2aa22c81bef_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.1 (rare missense variant + WES)\n+0.2 (Complex IV activity by OxPhos 42% of control, parents were normal + maximal respiratory rate OCR in glucose and galcatose was 45-46% of control by OCR)\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/bb8ccf36-5632-4018-88a7-c2aa22c81bef_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34322155","allele":{"id":"https://genegraph.clinicalgenome.org/r/8f472586-4776-4729-9857-906bab76cb3f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_023077.3(COA7):c.566A>G (p.Asn189Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA855634"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.25},{"id":"https://genegraph.clinicalgenome.org/r/3acabed4-9f68-4fd6-95e9-ef05d58bea6c","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/34322155","rdfs:label":"Ban et al 2021","ageType":"AgeAtOnset","ageUnit":"Months","ageValue":3,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/4ce03fda-9521-470c-8669-6aab9cdb5904"},{"id":"https://genegraph.clinicalgenome.org/r/8f472586-4776-4729-9857-906bab76cb3f"}],"detectionMethod":"Comp. Het\nc.511G>A; p.A171T\n(maternal)\n\ngnomAD v4.1.0 -2  alleles no homozygotes (AF 0.000001239)\n\nc.566A>G;p.Asn189Ser\n(paternal)\n\ngnomAD v4.1.0 – 6 alleles no homozygotes (AF 0.000003717)\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001257","obo:HP_0002151","obo:HP_0001276","obo:HP_0001270","obo:HP_0001638","obo:HP_0033044","obo:HP_0008180"],"secondTestingMethod":"Sanger sequencing","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/bb8ccf36-5632-4018-88a7-c2aa22c81bef_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/ddeadc70-8168-4d4b-90f6-a26534f8366d_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/ad572e76-b639-4735-87e1-876cf55497c1_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f43f5e3-b210-4d53-bc08-1f0b273d43a0","type":"EvidenceLine","dc:description":"1.5 (Default null)\n+0.5 (wt COA7 transduced into patient fibroblasts and rescued MT-CO2, subunit and COX assembly and in gel activity) \n","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/7f43f5e3-b210-4d53-bc08-1f0b273d43a0_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"1.5 (Default null)\n+0.5 (wt COA7 transduced into patient fibroblasts and rescued MT-CO2, subunit and COX assembly and in gel activity) \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/7f43f5e3-b210-4d53-bc08-1f0b273d43a0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27683825","allele":{"id":"https://genegraph.clinicalgenome.org/r/047fdd4a-9f47-4a2b-84b7-73302eedf926","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_023077.3(COA7):c.247+1G>T","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340348544"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/44c4de45-b91a-4c11-b703-c45c6d0afa2e","type":"EvidenceLine","dc:description":"0.1 (Default missense)\n+ 0.4 (absence of COA7, MT-CO2, MT-COIII)\n+0.4 (wt COA7 transduced into patient fibroblasts and rescued MT-CO2, subunit and COX assembly and in gel activity) \n","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/44c4de45-b91a-4c11-b703-c45c6d0afa2e_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.1 (Default missense)\n+ 0.4 (absence of COA7, MT-CO2, MT-COIII)\n+0.4 (wt COA7 transduced into patient fibroblasts and rescued MT-CO2, subunit and COX assembly and in gel activity) \n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/44c4de45-b91a-4c11-b703-c45c6d0afa2e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27683825","allele":{"id":"https://genegraph.clinicalgenome.org/r/bfc55c6e-ce74-4e60-a5f8-a4e926ea87c6","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_023077.3(COA7):c.410A>G (p.Tyr137Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA22543777"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/ad572e76-b639-4735-87e1-876cf55497c1","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/27683825","rdfs:label":"Martinez Lyons proband","ageType":"AgeAtReport","ageUnit":"Years","ageValue":19,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/047fdd4a-9f47-4a2b-84b7-73302eedf926"},{"id":"https://genegraph.clinicalgenome.org/r/bfc55c6e-ce74-4e60-a5f8-a4e926ea87c6"}],"detectionMethod":"WES + mtDNA sequencing\n\n(NM_023077) c.287+1G>T\n(maternal)\n\n(aka c.247+1G>T)\n2 alleles in gnomAD (AF 0.000001239)\n\n\n(NM_023077) c.410A>G; p.Y137C\n(paternal)\n7 alleles in gnomAD v4.1.0\n(AF  0.000004337)\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0009830","obo:HP_0001310","obo:HP_0001260","obo:HP_0001270","obo:HP_0001337","obo:HP_0001251","obo:HP_0002415"],"secondTestingMethod":"Next generation sequencing panels","sex":"Female","variant":[{"id":"https://genegraph.clinicalgenome.org/r/44c4de45-b91a-4c11-b703-c45c6d0afa2e_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/7f43f5e3-b210-4d53-bc08-1f0b273d43a0_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/2c83351d-5b78-4e76-b596-b1a8adeef858_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2c97da4-d98c-4e4d-a1e6-669a37a84837","type":"EvidenceLine","dc:description":"0.1 (rare missense variant + WES)\n+0.2 (complex IV deficiency in fibroblasts by ETC 9% of control)\n+0.2 (decreased complex IV by immunoblot and BN PAGE)\n+0.4 Rescue  S149I fails to rescue COX1 and COX2 levels in COA7 KO cells where WT substantially recovered PMID: 35210360\n","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/c2c97da4-d98c-4e4d-a1e6-669a37a84837_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"0.1 (rare missense variant + WES)\n+0.2 (complex IV deficiency in fibroblasts by ETC 9% of control)\n+0.2 (decreased complex IV by immunoblot and BN PAGE)\n+0.4 Rescue  S149I fails to rescue COX1 and COX2 levels in COA7 KO cells where WT substantially recovered PMID: 35210360\n","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/c2c97da4-d98c-4e4d-a1e6-669a37a84837_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29718187","allele":{"id":"https://genegraph.clinicalgenome.org/r/84265944-ac83-4c98-81bb-9b19d35a5058","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_023077.3(COA7):c.446G>T (p.Ser149Ile)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340363032"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/14bb4cd9-d16c-4a61-a1a3-f394b828b72a","type":"EvidenceLine","dc:description":"Recurrent variant, suspected founder - score 0.5","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/14bb4cd9-d16c-4a61-a1a3-f394b828b72a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Recurrent variant, suspected founder","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/14bb4cd9-d16c-4a61-a1a3-f394b828b72a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29718187","allele":{"id":"https://genegraph.clinicalgenome.org/r/8ffd2fc1-6380-42fa-9417-74e1937728fd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"No","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/2c83351d-5b78-4e76-b596-b1a8adeef858","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29718187","rdfs:label":"Higuchi et al 2018, Patient 3","ageType":"AgeAtOnset","ageUnit":"Years","ageValue":15,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/8ffd2fc1-6380-42fa-9417-74e1937728fd"},{"id":"https://genegraph.clinicalgenome.org/r/84265944-ac83-4c98-81bb-9b19d35a5058"}],"detectionMethod":"Comp. Het\nc.17A>G; p. D6G \n(Son A carries)\n14 alleles in gnomAD v4.1.0 (no homozygotes, AF: 0.000008687)\n\nc.446 G>T; p.S149I\n(Son B carries)\nAbsent in gnomAD v4.1.0\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0001324","obo:HP_0001251","obo:HP_0003236","obo:HP_0001272","obo:HP_0009830","obo:HP_0003202"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/c2c97da4-d98c-4e4d-a1e6-669a37a84837_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/14bb4cd9-d16c-4a61-a1a3-f394b828b72a_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/6ed5cd37-e254-4397-8a1a-a6cf94134144_proband_score_evidence_line","type":"EvidenceLine","direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1fd6c1fe-7cc0-4a8d-bdc3-e77f92414ee0","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1fd6c1fe-7cc0-4a8d-bdc3-e77f92414ee0_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37750949","allele":{"id":"https://genegraph.clinicalgenome.org/r/4f1efe07-e17e-403c-a130-c201b18a9367","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_023077.3(COA7):c.449G>A (p.Cys150Tyr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA340363015"}},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/68935575-d3a0-40a0-886a-f61e283abe9b","type":"EvidenceLine","dc:description":"Recurrent founder - score 0.5 points","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/68935575-d3a0-40a0-886a-f61e283abe9b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Recurrent founder - score 0.5 points","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/68935575-d3a0-40a0-886a-f61e283abe9b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37750949","allele":{"id":"https://genegraph.clinicalgenome.org/r/8ffd2fc1-6380-42fa-9417-74e1937728fd"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"paternityMaternityConfirmed":"Yes","zygosity":{"id":"cg:TwoVariantsInTrans"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/6ed5cd37-e254-4397-8a1a-a6cf94134144","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/37750949","rdfs:label":"Higuchi et al 2024, family 1, patient 1","ageType":"AgeAtReport","ageUnit":"Years","ageValue":19,"allele":[{"id":"https://genegraph.clinicalgenome.org/r/8ffd2fc1-6380-42fa-9417-74e1937728fd"},{"id":"https://genegraph.clinicalgenome.org/r/4f1efe07-e17e-403c-a130-c201b18a9367"}],"detectionMethod":"Comp. Het\nc.449G>A;p.C150Y\n(Maternal)\nAbsent in gnomAD v4.1.0\n\nc.17A>G; p. D6G \n(Paternal)\n14 alleles in gnomAD v4.1.0 (no homozygotes, AF: 0.000008687)\n","firstTestingMethod":"Exome sequencing","phenotypes":["obo:HP_0002015","obo:HP_0001270","obo:HP_0009830","obo:HP_0001300","obo:HP_0001332","obo:HP_0001260"],"secondTestingMethod":"Sanger sequencing","sex":"Male","variant":[{"id":"https://genegraph.clinicalgenome.org/r/1fd6c1fe-7cc0-4a8d-bdc3-e77f92414ee0_variant_evidence_item"},{"id":"https://genegraph.clinicalgenome.org/r/68935575-d3a0-40a0-886a-f61e283abe9b_variant_evidence_item"}]}],"specifiedBy":"GeneValidityMaximumProbandScoreCriteria","strengthScore":0.6}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":10.85},{"id":"https://genegraph.clinicalgenome.org/r/971c1202-83cf-4ad1-9404-c4ef2fcf0880_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/971c1202-83cf-4ad1-9404-c4ef2fcf0880_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/42947899-e8da-4f3f-9d14-5ad7fd0c0e88","type":"EvidenceLine","dc:description":"Score 0.5 for drosophila model","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0b0241b9-a4f3-4d3b-88ca-e6ff57b9e70a","type":"Finding","dc:description":"Both have motor deficits; NMJ pathology\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29718187","rdfs:label":"Drosophila knockdown RNAi of COA7","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/f83578f7-9985-437b-9ac7-052e660d1611","type":"EvidenceLine","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/329af6b4-5de1-4452-bddb-88cef682f631","type":"Finding","dc:description":"Re-expression of COA7 rescues complex IV defect and supercomplex defects\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35210360","rdfs:label":"COA7 Rescue in HEK293T cells","demonstrates":{"id":"cg:PhenotypeRescue"}}],"specifiedBy":"GeneValidityCellCultureRescueCriteria","strengthScore":1}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/971c1202-83cf-4ad1-9404-c4ef2fcf0880_functional_alteration_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3479666-fcac-4298-b187-fdfd7ea10436","type":"EvidenceLine","dc:description":"Score 0.5 points for complex IV deficiency in fibroblasts","calculatedScore":1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0f7d15e4-432f-4004-9c63-53902e5a8cf1","type":"FunctionalAlteration","dc:description":"Fibroblasts show complex IV activity at 24% of control (corrected for CS)\n\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29718187","rdfs:label":"Patient 2 Fibroblasts studies "}],"specifiedBy":"GeneValidityPatientCellFunctionalAlterationCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/01b9134f-2e26-4a3b-8efb-800b01add7de","type":"EvidenceLine","dc:description":"Score 0.5 points  SDS PAGE import studies\nScore 0.5 points for aberrant Super complex assembly ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/4969ac5e-6c5a-4532-b9c7-ba5a503f9d53","type":"FunctionalAlteration","dc:description":"Mitochondrial import studies by radiolabeling NDUFS1, Core1 (III), COX6a, and complex V (F1B)\nFormation of mature complex IV reduced by more than 50% in the absence of C1orf163\nAlso saw decreased supercomplex formation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24333015","rdfs:label":"HeLa cells functional analysis SDS PAGE and Supercomplex"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/e0ecf073-eb6a-4f15-a82e-acbe1e93660d","type":"EvidenceLine","dc:description":"Score 0.5 points for shRNA knockdown of COA7 and subsequent effect on OxPhos proteins","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fcae90c6-1639-4d31-915b-1ac33f2dde22","type":"FunctionalAlteration","dc:description":"Mass spectrometry performed showed reduction on the order of 40-60% for a variety of complex I, III, IV and V subunits;Complex IV most strongly affected \nComplex II (SDHA) not affected at all; Performed a parallel control cell line treated with dox only without shRNA and no effect on any OXPHOS proteins tested; Similar results seen on Western and SDS page\n\n\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/24333015","rdfs:label":"HeLa cells functional analysis"}],"specifiedBy":"GeneValidityNonPatientCellFunctionalAlterationCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalAlterationEvidenceCriteria","strengthScore":2},{"id":"https://genegraph.clinicalgenome.org/r/971c1202-83cf-4ad1-9404-c4ef2fcf0880_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0506de3c-cbbd-4932-a36d-a0a6bdf84a10","type":"EvidenceLine","dc:description":">10 genes involved in complex IV assembly or heme binding activity ","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ee813c8a-d235-477c-9564-98dbcfd293b2","type":"Finding","dc:description":"Shows that COA7 results in specific deficits at the maturation of COX2 and/or COX3 modules of complex IV assembly\n\nSILAC proteomics performed on COA7 knockouts by CRISPR cas9 in HEK293T cells showed \nRobust decrease in COX2 (definitive) and COX3 (Definitive), COX4 (COX4I1 – limited) also dramatically decreased, COX6A1 (Strong), COX6B1 (definitive), COX7A2 (not curated), COX8A (limited), NDUFA4 (not curated)\n\nCross-linking proteomics on control cells and COA7 KO + COA7 Flag cells in glucose and galactose\n18 proteins common to glucose and galactose media including:\nCOA4, COA6,COX17,SCO2 (Definitive), OPA1, NDUFA8 (moderate)\n\nCOA7 binds Heme, but does not incorporate into CIV, however, reduces disulfide bonds in SCO1 (Definitive) and SCO2\nInteractome studies also identified COX15 (definitive), AIFM1 (moderate- Leigh syndrome), COA6 (Strong)\n","dc:source":"https://pubmed.ncbi.nlm.nih.gov/35210360","rdfs:label":"COA7 is a complex IV assembly factor ","demonstrates":{"id":"cg:BiochemicalFunctionA"}}],"specifiedBy":"GeneValidityBiochemicalFunctionCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":5.5}],"evidenceStrength":"Definitive","sequence":9773,"specifiedBy":"GeneValidityCriteria10","strengthScore":16.35,"subject":{"id":"https://genegraph.clinicalgenome.org/r/eYvCI7gFToE","type":"GeneValidityProposition","disease":"obo:MONDO_0044970","gene":"hgnc:25716","modeOfInheritance":"obo:HP_0000007"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_971c1202-83cf-4ad1-9404-c4ef2fcf0880-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}